Cleviprex Related Published Studies
Well-designed clinical trials related to Cleviprex (Clevidipine Butyrate)
Clevidipine for the treatment of severe hypertension in adults. [2010]
The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. [2008.10]
Treatment of acute postoperative hypertension in cardiac surgery patients: an efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, double-blind, placebo-controlled trial. [2008.07]
Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1. [2007.10]
Other research related to Cleviprex (Clevidipine Butyrate)
Clevidipine for severe hypertension in patients with renal dysfunction: a VELOCITY trial analysis. [2011.04]
Preliminary experience with clevidipine in the pediatric population. [2010.11]
Efficacy of clevidipine in controlling perioperative hypertension in neurosurgical patients: initial single-center experience. [2010.10]
Role of clevidipine butyrate in the treatment of acute hypertension in the critical care setting: a review. [2010.08.09]
Use of clevidipine for intraoperative hypertension caused by an undiagnosed pheochromocytoma: a case report. [2010.08]
Clevidipine: a short-acting intravenous dihydropyridine calcium channel blocker for the management of hypertension. [2010.05]
Clevidipine: a new intravenous option for the management of acute hypertension. [2010.03.01]
Clevidipine for severe hypertension in acute heart failure: a VELOCITY trial analysis. [2010.03]
Clevidipine butyrate: a promising new drug for the management of acute hypertension. [2010.02]
Clevidipine for the treatment of severe hypertension in adults. [2010.01]
Clevidipine: an ultra short-acting calcium channel antagonist for acute hypertension. [2009.07]
Clevidipine in the treatment of perioperative hypertension: assessing safety events in the ECLIPSE trials. [2009.05]
Clevidipine: a novel ultra-short-acting calcium antagonist. [2009.05]
Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension. [2009.03]
Clevidipine: a review of its use in the management of acute hypertension. [2009]
Drug evaluation of clevidipine for acute hypertension. [2008.10]
New therapeutic perspectives with clevidipine: an ultra-short-acting intravenous Ca2+ channel blocker. [2007.09]
Other possibly related research studies
Intravenous therapy for hypertensive emergencies, part 2. [2009.08.15]
[Treatment of peri- and postoperative hypertensive emergencies] [2009.04]
The diagnosis and treatment of hypertensive crises. [2009.01]
Perioperative hypertension management. [2008]
Gateways to clinical trials. [2008.06]
Gateways to clinical trials. [2008.01]
Treatment of acute severe hypertension: current and newer agents. [2008]
Gateways to clinical trials. [2007.07]
State of the art review: Intravenous fat emulsions: Current applications, safety profile, and clinical implications. [2010.04]
Acute severe arterial hypertension: therapeutic options. [2009.08]
Intravenous therapy for hypertensive emergencies, part 1. [2009.08.01]
Cardiovascular pharmacology: an update. [2010.12]
Hypertensive crisis. [2010.03]
A cost analysis of the impact of a new intravenous antihypertensive in managing
perioperative blood pressure during cardiac surgery. [2014]
|
